RxDoctor Payments Data

Daniel Kim, MD

Ophthalmology · Little Rock, ARNPI 1639444904

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 80 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $782, 3.2 times the $246 reported in 2019.

$2,340in general payments, 2019–2025

Across 80 payments — averaging $29.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$380
  • Regeneron Healthcare Solutions, Inc.$368
  • Alimera Sciences, Inc.$259
  • ANI Pharmaceuticals, Inc.$199
  • Genentech USA, Inc.$184
  • Apellis Pharmaceuticals, Inc.$165
  • plus $784 from 12 others

What the payments were for

  • Food & beverage$2,340100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,340 in reported general payments places this provider in the 80th percentile of 125 ophthalmology providers in Arkansas.

See all ophthalmology providers in Arkansas

Medicare billing

Part B allowed, 2024
$2,859,182
Medicare patients
772
Services billed
25,719

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate76$2,682
Difluprednate11$1,351
Atropine Sulfate41$1,224
Ketorolac Tromethamine16$540
ErythromycinErythromycin Base26$348
Ofloxacin22$249
Timolol Maleate37$220
Latanoprost19$124

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →